The novel coronavirus remains in the spotlight these days following more than two years of the pandemic. There have been a lot of discussions about the potential treatments for covid 19.
The latest treatments are addressed by WHO, and you can check out the latest reports below.
New covid treatments addressed by WHO
It’s been just revealed on the official WHO website that the organization is recommending two new drugs for treating covid 19.
It’s important to have new treatments for the disease that made the world pause for the past two years.
On the official WHO website, the extent to which these medicines will save lives depends on how widely available and affordable they will be.
The first drug is called baricitinib, and this is strongly recommended for patients with severe or critical covid 19 disease triggered by the novel coronavirus.
This is part of a class of drugs called Janus kinase (JAK) inhibitors that suppress the overstimulation of the immune system. WHO recommends that it is given with corticosteroids.
Check out the official notes revealed by the official WHO website.
“Baricitinib is an oral drug, used in the treatment of rheumatoid arthritis. It provides an alternative to other arthritis drugs called Interleukin-6 receptor blockers, recommended by WHO in July 2021.”
It’s also important to note the fact that WHO has also conditionally recommended the use of a monoclonal antibody drug, sotrovimab, for treating mild or moderate covid 19 in patients who are at high risk of hospitalization.
The official WHO website notes the following:
“This includes patients who are older, immunocompromised, having underlying conditions like diabetes, hypertension, and obesity, and those unvaccinated.”
There have been a lot of discussions about the necessity of covid drugs, especially during these times in which the vaccines are not taken by everyone due to their potential side effects. Stay tuned for more coronavirus-related news and also make sure to stay safe.